Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William McDonald is active.

Publication


Featured researches published by William McDonald.


The American Journal of Surgical Pathology | 2014

Clinicopathologic Features of Pediatric Oligodendrogliomas: A Series of 50 Patients

Fausto J. Rodriguez; Tarik Tihan; Doris Lin; William McDonald; Janice Nigro; Burt G. Feuerstein; Sadhana Jackson; Kenneth Cohen; Peter C. Burger

Oligodendrogliomas are an important adult form of diffuse gliomas with a distinctive clinical and genetic profile. Histologically similar tumors occurring rarely in children are incompletely characterized. We studied 50 patients with oligodendrogliomas (median age at diagnosis 8 y, range 7 mo to 20 y). Tumors resembling dysembryoplastic neuroepithelial tumors or pilocytic astrocytomas or those having a “mixed” histology were excluded. Tumors at first diagnosis were low grade (n=38) or anaplastic (n=12). Histologic features included uniform round cells with perinuclear halos (100%), secondary structures (predominantly perineuronal satellitosis) (90%), calcifications (46%), and microcysts (44%). Sequential surgical specimens were obtained in 8 low-grade oligodendroglioma patients, with only 1 progressing to anaplasia. Studies for 1p19q performed in 40 cases demonstrated intact 1p19q loci in 29 (73%), 1p19q codeletion in 10 (25%), and 1p deletion with intact 19q in 1 (2%). Except for 2 young patients (3 and 11 y of age), patients with 1p19q codeletion were older than 16 years at diagnosis. Mutant IDH1 (R132H) protein immunohistochemistry was positive in 4 (of 22) (18%) cases, 3 of which also had 1p19q codeletion, whereas 1p19q status was not available on the fourth case. There was a nonsignificant trend for worse overall survival in grade III tumors, but no significant association with age, extent of resection, or 1p19q status. In summary, oligodendrogliomas with classic histology occur in the pediatric population but lack 1p19q codeletion and IDH1 (R132H) mutations in most instances. They are predominantly low grade, recur/clinically progress in a subset, but demonstrate a relatively low frequency of histologic progression.


Archives of Pathology & Laboratory Medicine | 2017

Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone: A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma

William McDonald; Nilanjana Banerji; Kelsey McDonald; Bridget Ho; Virgilia Macias; Andre Kajdacsy-Balla

CONTEXT -Pituitary adenoma classification is complex, and diagnostic strategies vary greatly from laboratory to laboratory. No optimal diagnostic algorithm has been defined. OBJECTIVE -To develop a panel of immunohistochemical (IHC) stains that provides the optimal combination of cost, accuracy, and ease of use. DESIGN -We examined 136 pituitary adenomas with stains of steroidogenic factor 1 (SF-1), Pit-1, anterior pituitary hormones, cytokeratin CAM5.2, and α subunit of human chorionic gonadotropin. Immunohistochemical staining was scored using the Allred system. Adenomas were assigned to a gold standard class based on IHC results and available clinical and serologic information. Correlation and cluster analyses were used to develop an algorithm for parsimoniously classifying adenomas. RESULTS -The algorithm entailed a 1- or 2-step process: (1) a screening step consisting of IHC stains for SF-1, Pit-1, and adrenocorticotropic hormone; and (2) when screening IHC pattern and clinical history were not clearly gonadotrophic (SF-1 positive only), corticotrophic (adrenocorticotropic hormone positive only), or IHC null cell (negative-screening IHC), we subsequently used IHC for prolactin, growth hormone, thyroid-stimulating hormone, and cytokeratin CAM5.2. CONCLUSIONS -Comparison between diagnoses generated by our algorithm and the gold standard diagnoses showed excellent agreement. When compared with a commonly used panel using 6 IHC for anterior pituitary hormones plus IHC for a low-molecular-weight cytokeratin in certain tumors, our algorithm uses approximately one-third fewer IHC stains and detects gonadotroph adenomas with greater sensitivity.


Clinical Neurology and Neurosurgery | 2018

Extradural petromastoid calcifying pseudoneoplasm of the neuraxis (CAPNON): Case report and literature review

Eric S. Nussbaum; Chris Hilton; Archie Defillo; William McDonald; Theodore Passe; Kevin M. Kallmes; Leslie A. Nussbaum

BACKGROUND Calcifying pseudoneoplasm of the neuraxis (CAPNON) is a very rare tumor with fewer than 70 cases reported in the literature. In general, this tumor occurs intracranially either within the brain parenchyma or in an extra-axial location, but it has also been described within the spine as an extra-axial lesion. CASE DESCRIPTION We describe an unusual case of intracranial-extradural CAPNON involving the mastoid region. This may be only the second such case reported in the literature, as one patient with CAPNON has been reported involving the sinonasal region. Our patient was managed with surgical resection through a translabyrinthine approach with good early result. CONCLUSIONS We describe an unusual case of extradural CAPNON involving the mastoid bone. It appears that when located extradurally, this tumor may have a predilection for the bony sinuses. This little-known, generally benign entity can mimic more common lesions such as meningiomas, and should be considered in the differential diagnosis of skull base tumors, particularly when associated with heavy calcification.


Histopathology | 2016

Compound gonadotrophic pituitary adenoma and rhabdomyosarcoma

Ana Cristina Araujo Lemos de Silva; Fausto J. Rodriguez; Iban Aldecoa; William McDonald; Teresa Ribalta

2011; 19; 104–109. 4. Torres Gomez FJ, Fernandez Machin P, Garcia Suarez RM. Right orchiectomy: inflammatory testicular pseudotumor. Archiv. Esp. Urol. 2012; 65; 641–642. 5. Navai N, Yap RL, Gupta R et al. Inflammatory pseudotumor of the testis: a novel presentation of acute retroviral syndrome. Int. J. Urol. 2005; 12; 424–426. 6. Lovly CM, Gupta A, Lipson D et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014; 4; 889–895. 7. Fujita H, Yoshida A, Taniguchi H et al. Adult-onset inflammatory myofibroblastic tumour of the stomach with a TFG–ROS1 fusion. Histopathology 2015; 66; 610–612. 8. Butrynski JE, D’Adamo DR, Hornick JL et al. Crizotinib in ALKrearranged inflammatory myofibroblastic tumor. N. Engl. J. Med. 2010; 363; 1727–1733.


Journal of Neuropathology and Experimental Neurology | 2018

Sellar Region Atypical Teratoid/Rhabdoid Tumors in Adults: Clinicopathological Characterization of Five Cases and Review of the Literature

Michael A. Paolini; Benjamin R. Kipp; William R. Sukov; Sarah M. Jenkins; Emily G. Barr Fritcher; Derick Aranda; Karen S. SantaCruz; Sadeq Al-Dandan; Pete Fisher; William McDonald; Charles P Bondurant; Grant Van Dyke Darkow; Caterina Giannini; Joseph E. Parisi; Mark E. Jentoft; Aditya Raghunathan

Atypical teratoid/rhabdoid tumors (AT/RTs) are highly malignant CNS neoplasms that typically occur in children <2 years of age. These are characterized by high-grade histologic features and mutations of the INI1/SMARCB1 gene readily detected by loss of expression by immunohistochemistry. Among adults, the majority of AT/RTs occurs in the cerebral hemispheres. A small number of adult AT/RTs involving the sellar and suprasellar region reported in the literature suggest a distinct clinical course for this group. Here, we describe detailed clinical and genetic characterization of 5 adult patients with AT/RTs involving the sellar and suprasellar region, and provide a review of the available clinical and genetic features of 22 previously reported cases in order to help increase our understanding of this unusual entity.


Oncotarget | 2014

PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors.

Maoyu Peng; Rajyasree Emmadi; Zebin Wang; Elizabeth L. Wiley; Peter H. Gann; Seema A. Khan; Nilanjana Banerji; William McDonald; Szilard Asztalos; Thao Pham; Debra A. Tonetti; Angela L. Tyner


SpringerPlus | 2015

High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature

Szilard Asztalos; Thao Pham; Peter H. Gann; Meghan K. Hayes; Ryan Deaton; Elizabeth L. Wiley; Rajyasree Emmadi; Andre Kajdacsy-Balla; Nilanjana Banerji; William McDonald; Seema A. Khan; Debra A. Tonetti


Archive | 2014

Clinicopathologic Features of Pediatric Oligodendrogliomas

Fausto J. Rodriguez; Tarik Tihan; Doris Lin; William McDonald; Janice Nigro; Burt G. Feuerstein; Sadhana Jackson; Kenneth Cohen; Peter C. Burger


Cancer Research | 2013

Abstract 4380: Splicing factor SRSF3 knockdown-induced breast cancer cell growth suppression and apoptosis is partially reversed by Z-VAD-FMK and its expression correlates malignancy of breast cancer.

Tsui-Ting Ho; Szilard Asztalos; Neena Majumdar; Ahmet Dirim Arslan; Martha R. Stampfer; Elizabeth L. Wiley; Seema A. Khan; Nilanjana Banerji; William McDonald; Xiaolong He; Debra A. Tonetti; William T. Beck


The FASEB Journal | 2007

POLG1 mutations in two children with seizures and progressive, fatal encephalopathy

William McDonald; Timothy Casey; Theodore Passe; Frank Ritter

Collaboration


Dive into the William McDonald's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Debra A. Tonetti

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Elizabeth L. Wiley

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Fausto J. Rodriguez

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Szilard Asztalos

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Andre Kajdacsy-Balla

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Burt G. Feuerstein

St. Joseph's Hospital and Medical Center

View shared research outputs
Top Co-Authors

Avatar

Doris Lin

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Janice Nigro

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge